Cargando…

Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection

BACKGROUND: Ischemic stroke patients are prone to infection by stroke-induced immunodepression. We hypothesized that levels of lipopolysaccharide binding protein (LBP), interleukin-10 (IL-10), IL-6 and C-reactive protein (CRP) are early predictors for the development of stroke-associated infection....

Descripción completa

Detalles Bibliográficos
Autores principales: Worthmann, Hans, Tryc, Anita B, Dirks, Meike, Schuppner, Ramona, Brand, Korbinian, Klawonn, Frank, Lichtinghagen, Ralf, Weissenborn, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307994/
https://www.ncbi.nlm.nih.gov/pubmed/25613713
http://dx.doi.org/10.1186/s12974-014-0231-2
_version_ 1782354529347436544
author Worthmann, Hans
Tryc, Anita B
Dirks, Meike
Schuppner, Ramona
Brand, Korbinian
Klawonn, Frank
Lichtinghagen, Ralf
Weissenborn, Karin
author_facet Worthmann, Hans
Tryc, Anita B
Dirks, Meike
Schuppner, Ramona
Brand, Korbinian
Klawonn, Frank
Lichtinghagen, Ralf
Weissenborn, Karin
author_sort Worthmann, Hans
collection PubMed
description BACKGROUND: Ischemic stroke patients are prone to infection by stroke-induced immunodepression. We hypothesized that levels of lipopolysaccharide binding protein (LBP), interleukin-10 (IL-10), IL-6 and C-reactive protein (CRP) are early predictors for the development of stroke-associated infection. METHODS: Fifty-six patients with ischemic stroke (n = 51) and transient ischemic attack (TIA) (n = 5) who presented within 6 hours after symptom onset and who were free of detectable infection on admission were included in the study. Of these, 20 developed early infections during the first week. Blood samples were taken at 6, 12, and 24 hours and at 3 and 7 days after stroke onset. Levels of LBP, Il-10, IL-6 and CRP, as well as S100B, were measured as markers of inflammation and brain damage by commercially available immunometric tests. RESULTS: In the univariate analysis, levels of LBP, IL-10, IL-6 and CRP significantly differed between patients who developed an infection and those who did not. In the binary logistic regression analysis, which was adjusted for National Institutes of Health Stroke Scale (NIHSS) on admission, stroke subtype and S100B peak levels, as indicator of the extent of brain damage, IL-10 at 6 hours, CRP at 6 hours and NIHSS on admission were identified as independent predictors of infection (IL-10: P = 0.009; CRP: P = 0.018; NIHSS: P = 0.041). The area under the curve (AUC) of the receiver operating characteristic (ROC) curves in relation to the dichotomized status of the infection (infection versus no infection) was 0.74 (95% confidence interval: 0.59 to 0.88) for CRP at 6 hours, 0.76 (0.61 to 0.9) for IL-10 at 6 hours, 0.83 (0.71 to 0.94) for NIHSS on admission and 0.94 (0.88 to 1) for the combination of CRP, IL-10 and NIHSS. In a subanalysis, 16 patients with early infections were matched with 16 patients without infection according to S100B peak levels. Here, the temporal pattern of LBP, IL-10, IL-6 and CRP significantly differed between the patient groups. CONCLUSIONS: Our data show that blood levels of inflammation markers may be used as early predictors of stroke-associated infection. We propose prospective studies to investigate if the calculated cut-offs of CRP, IL-10 and NIHSS might help to identify patients who should receive early preventive antibiotic treatment.
format Online
Article
Text
id pubmed-4307994
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43079942015-01-28 Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection Worthmann, Hans Tryc, Anita B Dirks, Meike Schuppner, Ramona Brand, Korbinian Klawonn, Frank Lichtinghagen, Ralf Weissenborn, Karin J Neuroinflammation Research BACKGROUND: Ischemic stroke patients are prone to infection by stroke-induced immunodepression. We hypothesized that levels of lipopolysaccharide binding protein (LBP), interleukin-10 (IL-10), IL-6 and C-reactive protein (CRP) are early predictors for the development of stroke-associated infection. METHODS: Fifty-six patients with ischemic stroke (n = 51) and transient ischemic attack (TIA) (n = 5) who presented within 6 hours after symptom onset and who were free of detectable infection on admission were included in the study. Of these, 20 developed early infections during the first week. Blood samples were taken at 6, 12, and 24 hours and at 3 and 7 days after stroke onset. Levels of LBP, Il-10, IL-6 and CRP, as well as S100B, were measured as markers of inflammation and brain damage by commercially available immunometric tests. RESULTS: In the univariate analysis, levels of LBP, IL-10, IL-6 and CRP significantly differed between patients who developed an infection and those who did not. In the binary logistic regression analysis, which was adjusted for National Institutes of Health Stroke Scale (NIHSS) on admission, stroke subtype and S100B peak levels, as indicator of the extent of brain damage, IL-10 at 6 hours, CRP at 6 hours and NIHSS on admission were identified as independent predictors of infection (IL-10: P = 0.009; CRP: P = 0.018; NIHSS: P = 0.041). The area under the curve (AUC) of the receiver operating characteristic (ROC) curves in relation to the dichotomized status of the infection (infection versus no infection) was 0.74 (95% confidence interval: 0.59 to 0.88) for CRP at 6 hours, 0.76 (0.61 to 0.9) for IL-10 at 6 hours, 0.83 (0.71 to 0.94) for NIHSS on admission and 0.94 (0.88 to 1) for the combination of CRP, IL-10 and NIHSS. In a subanalysis, 16 patients with early infections were matched with 16 patients without infection according to S100B peak levels. Here, the temporal pattern of LBP, IL-10, IL-6 and CRP significantly differed between the patient groups. CONCLUSIONS: Our data show that blood levels of inflammation markers may be used as early predictors of stroke-associated infection. We propose prospective studies to investigate if the calculated cut-offs of CRP, IL-10 and NIHSS might help to identify patients who should receive early preventive antibiotic treatment. BioMed Central 2015-01-23 /pmc/articles/PMC4307994/ /pubmed/25613713 http://dx.doi.org/10.1186/s12974-014-0231-2 Text en © Worthmann et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Worthmann, Hans
Tryc, Anita B
Dirks, Meike
Schuppner, Ramona
Brand, Korbinian
Klawonn, Frank
Lichtinghagen, Ralf
Weissenborn, Karin
Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
title Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
title_full Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
title_fullStr Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
title_full_unstemmed Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
title_short Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
title_sort lipopolysaccharide binding protein, interleukin-10, interleukin-6 and c-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307994/
https://www.ncbi.nlm.nih.gov/pubmed/25613713
http://dx.doi.org/10.1186/s12974-014-0231-2
work_keys_str_mv AT worthmannhans lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection
AT trycanitab lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection
AT dirksmeike lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection
AT schuppnerramona lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection
AT brandkorbinian lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection
AT klawonnfrank lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection
AT lichtinghagenralf lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection
AT weissenbornkarin lipopolysaccharidebindingproteininterleukin10interleukin6andcreactiveproteinbloodlevelsinacuteischemicstrokepatientswithpoststrokeinfection